Technology

Optellum Raises $14M in Series A Financing

Tavros Therapeutics Raises $7.5M to Advance Biomarker-Directed Cancer Drug Discovery Platform

WEHI Launches Project to Improve Genomic Data Interpretation, Precision Cancer Care in Australia

Universal Genetic Testing in Breast Cancer Further Supported in New Invitae-Led Study

Persephone Biosciences Enrolls First Patient in Study of Microbiome Effect on Cancer Drug Response

Abpro Licenses HER2-Targeteing Bispecific Antibody to Celltrion

Liquid Biopsy Firm Hedera Dx Raises €14M in Seed Funding

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib

Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients

Verismo Therapeutics to Begin Phase I Trial of Autologous Cell Therapy SynKIR-110

EMA's CHMP Recommends Gilead's Yescarta for Second-Line Lymphoma

Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests

Biocytogen Pharmaceuticals, Guangzhou FineImmune Biotechnology Ink Cell Therapy Partnership

Imaging Agent May Have Potential as Noninvasive Test to Predict PARP Inhibitor Response